| Literature DB >> 33637520 |
Tom Hodgkinson1,2, P Monica Tsimbouri1, Virginia Llopis-Hernandez1, Paul Campsie3, David Scurr4, Peter G Childs5, David Phillips6, Sam Donnelly1, Julia A Wells7, Fergal J O'Brien2, Manuel Salmeron-Sanchez5, Karl Burgess8, Morgan Alexander4, Massimo Vassalli5, Richard O C Oreffo7, Stuart Reid3, David J France6, Matthew J Dalby9.
Abstract
Bioactive metabolites have wide-ranging biological activities and are a potential source of future research and therapeutic tools. Here, we use nanovibrational stimulation to induce osteogenic differentiation of mesenchymal stem cells, in the absence of off-target, nonosteogenic differentiation. We show that this differentiation method, which does not rely on the addition of exogenous growth factors to culture media, provides an artifact-free approach to identifying bioactive metabolites that specifically and potently induce osteogenesis. We first identify a highly specific metabolite, cholesterol sulfate, an endogenous steroid. Next, a screen of other small molecules with a similar steroid scaffold identified fludrocortisone acetate with both specific and highly potent osteogenic-inducing activity. Further, we implicate cytoskeletal contractility as a measure of osteogenic potency and cell stiffness as a measure of specificity. These findings demonstrate that physical principles can be used to identify bioactive metabolites and then enable optimization of metabolite potency can be optimized by examining structure-function relationships.Entities:
Mesh:
Year: 2021 PMID: 33637520 PMCID: PMC7909882 DOI: 10.1126/sciadv.abb7921
Source DB: PubMed Journal: Sci Adv ISSN: 2375-2548 Impact factor: 14.136